Showing results (111-120 of 516) with videos related to
Sort By:
Pageof 52
Diagnostic Microbiology and Infectious Disease|November 28, 2018
In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016)Leonard R Duncan, Robert K Flamm, Helio S Sader, et al.The Journal of Antimicrobial Chemotherapy|September 18, 2010
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumoniaMichael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.Antimicrobial Agents and Chemotherapy|April 14, 2010
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolatesRodrigo E Mendes, Gary J Moet, Mike J Janechek, et al.Journal of Global Antimicrobial Resistance|July 21, 2019
Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016Leonard R Duncan, Caitlin J Smith, Robert K Flamm, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 15, 2021
Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017-2019)Cecilia G Carvalhaes, Helio S Sader, Paul R Rhomberg, et al.Diagnostic Microbiology and Infectious Disease|October 20, 2010
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 24, 2010
Human monocytes tolerant to LPS retain the ability to phagocytose bacteria and generate reactive oxygen speciesM L Fernandes, M E Mendes, M K C Brunialti, et al.Diagnostic Microbiology and Infectious Disease|February 18, 2010
Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102)Douglas J Biedenbach, Paul R Rhomberg, Rodrigo E Mendes, et al.Diagnostic Microbiology and Infectious Disease|November 17, 2009
Linezolid surveillance program results for 2008 (LEADER Program for 2008)David J Farrell, Rodrigo E Mendes, James E Ross, et al.Antimicrobial Agents and Chemotherapy|June 13, 2012
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitalsRodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, et al.Pageof 52